Biopharmaceutical Classification System : An Account

@inproceedings{Yasir2003BiopharmaceuticalCS,
  title={Biopharmaceutical Classification System : An Account},
  author={Mohd. Yasir and Mohd Asif and Ashwani Kumar},
  year={2003}
}
In 1995, Amidon and coworkers introduced the biopharmaceutical classification system (BCS) to reduce the need for in vivo bioequivalency studies, utilization of in vitro dissolution tests as a surrogate for in vivo bioequivalence studies. The principles of the BCS classification system can be applied to NDA and ANDA approvals as well as to scaleup and post approval changes in drug manufacturing. Therefore, can save significant amount of product development time of pharmaceutical companies and… CONTINUE READING
20 Extracted Citations
30 Extracted References
Similar Papers

Citing Papers

Publications influenced by this paper.
Showing 1-10 of 20 extracted citations

Referenced Papers

Publications referenced by this paper.
Showing 1-10 of 30 references

Application and experience in the EU of BCS in the review of new generics

  • DM Barends
  • J. Pharm.Pharmacol,
  • 2005

Biopharmaceutical classification system and its importance,

  • RK Khar, D Pandita
  • The Indian Pharmacist. March 2005,
  • 2005
2 Excerpts

Dissolution: a promising tool in drug delivery,

  • A Ahuja, S Baboota, J Ali
  • Indian J. Pharm. Sci.,
  • 2005
2 Excerpts

Similar Papers

Loading similar papers…